Skip to content
Antazoline
Vasocon-a (antazoline) is a small molecule pharmaceutical. Antazoline was first approved as Vasocon-a on 1994-07-11. It is used to treat allergic conjunctivitis, pruritus, and respiration disorders in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
respiratory tract diseasesD012140
eye diseasesD005128
skin and connective tissue diseasesD017437
immune system diseasesD007154
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Antazoline phosphate
+
Naphazoline hydrochloride
Tradename
Company
Number
Date
Products
VASOCON-ANovartisN-018746 DISCN1994-07-11
1 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
allergic conjunctivitisEFO_0007141D003233H10.44
pruritusHP_0000989D011537L29
respiration disorders—D012120J00-J99
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
R: Respiratory system drugs
— R01: Nasal preparations
— R01A: Decongestants and other nasal preparations for topical use
— R01AC: Antiallergic nasal preparations for topical use, excl. corticosteroids
— R01AC04: Antazoline
— R06: Antihistamines for systemic use
— R06A: Antihistamines for systemic use
— R06AX: Other antihistamines for systemic use in atc
— R06AX05: Antazoline
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameANTAZOLINE
INNantazoline
Description
Antazoline is a member of the class of imidazolines that is 2-aminomethyl-2-imidazoline in which the exocyclic amino hydrogens are replaced by benzyl and phenyl groups. Antazoline is only found in individuals that have taken the drug. It has a role as a H1-receptor antagonist, a cholinergic antagonist and a xenobiotic. It is a tertiary amino compound, an aromatic amine and a member of imidazolines.
Classification
Small molecule
Drug classantihistamines/local vasoconstrictors (antazoline type)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1
Identifiers
PDB—
CAS-ID91-75-8
RxCUI865
ChEMBL IDCHEMBL1305
ChEBI ID84115
PubChem CID2200
DrugBankDB08799
UNII IDDHA8014SS1 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 279 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
6 adverse events reported
View more details